Listening to patients: can tracking daily life predict cancer treatment success?
NCT ID NCT07061379
Summary
This study aims to understand how different first-line chemo-immunotherapy combinations affect the daily lives and well-being of people with advanced lung cancer. Researchers will ask 144 participants to complete regular online questionnaires about their quality of life, symptoms, emotional health, sleep, and sexuality. The goal is to see if tracking these patient-reported experiences can provide useful information about treatment effectiveness beyond traditional medical tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Ospedale San Raffaele
RECRUITINGMilan, Italy, 20132, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.